And anti-mycobacterial drug that inhibits mycobacterial ATP synthetase and depletes cellular energy stores.
Differs from other anti-mycobacterial drugs and therefore it has the capacity to retain activity against some M tuberculosis isolates resistant to other drugs.
Bedaquiline-pretomanid-linezolid regimen has a 90% efficacy against highly drug-resistant tuberculosis.